Sakuma Yoko, Li Ziaodong, Pilbeam Carol C, Alander Cynthia B, Chikazu Daichi, Kawaguchi Hiroshi, Raisz Lawrence G
Department of Medicine, University of Connecticut Health Center, Farmington, CT 06030, USA.
Bone. 2004 May;34(5):827-34. doi: 10.1016/j.bone.2003.12.007.
Prostaglandins (PGs), particularly PGE(2), can stimulate bone resorption and formation and auto-amplify their effects by inducing cyclooxygenase (COX)-2. We examined the role of different PG receptors in stimulating cAMP production and COX-2 expression in murine calvarial osteoblasts. Cells were obtained from PGE(2) receptor (EP2R and EP4R) wild-type and knockout (KO) mice and from mice transgenic for the COX-2 promoter fused to a luciferase reporter. We analyzed effects of selective agonists, EP2A and EP4A, for EP2R and EP4R, which mediate the increase in cAMP in response to PGE(2). We also tested agonists for other PGE(2) receptors (EP1A and EP3A) and for prostacyclin (IPA), prostaglandin D(2) (DPA), thromboxane (TPA), and prostaglandin F(2alpha) (FPA) receptors. PGE(2) and EP2A were the most effective stimulators of cAMP production. EP4A, IPA, and DPA produced smaller responses, and EP1A, EP3A, FPA, and TPA were ineffective. In EP2R KO cells, cAMP responses to PGE(2) were reduced by 80%, and responses to EP2A were abrogated. In EP4R KO cells, cAMP responses to PGE(2) and EP2A showed a small reduction, while the response to EP4A was abrogated. Pretreatment with PGE(2), EP2A, or EP4A down-regulated the subsequent response to the respective ligands. COX-2 induction was measured by increased luciferase activity and mRNA expression. PGE(2) was the most effective agonist; EP2A and another selective EP2R agonist, butaprost, showed similar efficacy, and EP4A was less effective. EP2A and EP4A effects on luciferase activity were additive, and effects of the combination were similar to PGE(2) itself. IPA, TPA, and DPA produced 2- to 6-fold increases in COX-2 expression. FPA was a weak agonist, while EP1A and EP3A were inactive. Treatment with specific inhibitors indicated that PGE(2), EP2A, and EP4A induced COX-2 expression largely through protein kinase A (PKA). We conclude that the PG induction of COX-2 in this system generally paralleled effects on cAMP production and was mediated predominantly via the PKA pathway.
前列腺素(PGs),尤其是前列腺素E2(PGE2),可刺激骨吸收和骨形成,并通过诱导环氧化酶(COX)-2来自动放大其效应。我们研究了不同PG受体在刺激小鼠颅骨成骨细胞中环磷酸腺苷(cAMP)产生和COX-2表达方面的作用。细胞取自PGE2受体(EP2R和EP4R)野生型和敲除(KO)小鼠,以及转染了与荧光素酶报告基因融合的COX-2启动子的小鼠。我们分析了EP2R和EP4R的选择性激动剂EP2A和EP4A的作用,它们介导了对PGE2刺激的cAMP增加。我们还测试了其他PGE2受体(EP1A和EP3A)以及前列环素(IPA)、前列腺素D2(DPA)、血栓素(TPA)和前列腺素F2α(FPA)受体的激动剂。PGE2和EP2A是cAMP产生的最有效刺激剂。EP4A、IPA和DPA产生的反应较小,而EP1A、EP3A、FPA和TPA无效。在EP2R基因敲除细胞中,对PGE2的cAMP反应降低了80%,对EP2A的反应则完全消除。在EP4R基因敲除细胞中,对PGE2和EP2A的cAMP反应略有降低,而对EP4A的反应则完全消除。用PGE2、EP2A或EP4A预处理可下调随后对相应配体的反应。通过荧光素酶活性增加和mRNA表达来测量COX-2的诱导情况。PGE2是最有效的激动剂;EP2A和另一种选择性EP2R激动剂布他前列素显示出相似的效力,而EP4A效力较弱。EP2A和EP4A对荧光素酶活性的作用是相加的,且联合作用与PGE2本身相似。IPA、TPA和DPA使COX-2表达增加2至6倍。FPA是一种弱激动剂,而EP-1A和EP3A无活性。用特异性抑制剂处理表明,PGE2、EP2A和EP4A主要通过蛋白激酶A(PKA)诱导COX-2表达。我们得出结论,在该系统中PG对COX-2的诱导作用通常与对cAMP产生的作用平行,且主要通过PKA途径介导。